Sermonix Pharmaceuticals Inc. and Shanghai Henlius Biotech, Inc. announced a strategic collaboration agreement in which Henlius will receive exclusive rights to develop, manufacture and commercialize.
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SHANGHAI, Dec. 28, 2023 /PRNewswire/ Shanghai Henlius Biotech, Inc. (2696.HK) announces that recently, PT Kalbio Global Medika, the subsidiary of Henlius'
HANSIZHUANG Sets Sail in Indonesia Market sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Extensive Stage Small Cell Lung Cancer.